Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Epinephrine
Therapeutic Area : Immunology
Study Phase : Preclinical
Sponsor : Lovelace Biomedical
Deal Size : Not Applicable
Deal Type : Not Applicable
Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution in Canine Study
Details : Nasdepi (epinephrine) a small molecule, dry powder nasal formulation is currently being investigated for the treatment of patients with anaphylactic reactions due to severe allergies.
Brand Name : Nasdepi
Molecule Type : Small molecule
Upfront Cash : Not Applicable
July 09, 2024
Lead Product(s) : Epinephrine
Therapeutic Area : Immunology
Highest Development Status : Preclinical
Sponsor : Lovelace Biomedical
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?